What Researchers Did
Researchers treated two patients with intractable scleroderma-related extremity ulcers using 30 sessions of hyperbaric oxygen therapy (HBOT) after identifying local ischemia.
What They Found
Both patients, who had intractable bilateral extremity ulcers due to scleroderma, underwent 30 treatments of hyperbaric oxygen therapy (HBOT) at 2.4 ATA. All wounds healed successfully, marking the first reported successful use of HBOT for scleroderma ulcers.
What This Means for Canadian Patients
For Canadian patients with scleroderma experiencing difficult-to-heal ulcers, hyperbaric oxygen therapy (HBOT) could be a potential treatment option. This approach might offer relief for chronic wounds that have not responded to conventional therapies.
Canadian Relevance
This study, conducted by Canadian researchers, highlights a potential treatment for scleroderma ulcers, a condition affecting patients in Canada.
Study Limitations
A significant limitation of this study is its very small sample size, consisting of only two patients, which limits the generalizability of the findings.